Cargando…
Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial
Abstract: Hepatic toxicity is the most serious adverse effect of anti-tuberculosis drugs. This study was performed to evaluate the efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial, 70 new cases of pulmonary tuberculosis were divided into two group...
Autores principales: | Marjani, Majid, Baghaei, Parvaneh, Kazempour Dizaji, Mehdi, Gorji Bayani, Pegah, Fahimi, Fanak, Tabarsi, Payam, Velayati, Ali Akbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986122/ https://www.ncbi.nlm.nih.gov/pubmed/27610165 |
Ejemplares similares
-
Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019) -
The Effect of Garcin® in Preventing AntiTB-Induced Hepatitis in Newly Diagnosed Tuberculosis Patients
por: Tabarsi, Payam, et al.
Publicado: (2014) -
Value of third sputum smear for detection of pulmonary tuberculosis in HIV infected patients
por: Marjani, Majid, et al.
Publicado: (2012) -
Detection of Antibodies Against 6, 16 and 38 kDa Antigens of Mycobacterium tuberculosis as a Rapid Test for Diagnosis of Tuberculosis
por: Baghaei, Parvaneh, et al.
Publicado: (2011) -
Effect of pulmonary hypertension on outcome of pulmonary tuberculosis
por: Marjani, Majid, et al.
Publicado: (2014)